CASP8 and metabolic dysfunction-associated steatotic liver disease: The results showed that hsa_circ_0004535, and CASP8 were expressed at lower levels in NAFLD and T2DM patients than in controls, and even lower in T2DM with NAFLD patients, while hsa-miR-1827 was higher expression in T2DM with NAFLD than others.